Currently running — worth a closer look.
Running across 1 GEO.
Running in a single market (United States) — a focused test, not a broad rollout yet.
- 1 GEO
- Redirect chain checked
- LP host: forbes.com
Reverse-engineered from the live ad — longevity, GEOs, and the affiliate funnel behind it. Verified by following the redirect chain on Jun 14. Free, no login.
Funnel, reverse-engineered
The campaign behind this creative
← the actual path the money takes.
Creative
Forbes | Sponsored
Landing page
forbes.com
where it lands
Product / Offer: not detected
Tracker: not detected
Affiliate network: not detected
How we know: the tracker and affiliate network come from the live redirect chain we followed and fingerprinted hop by hop. Greyed nodes weren’t detected.
Active
last seen 2d ago · 1 market
Running with a modest observed footprint so far.
Gravity
33/100
push pressure now · 30d index
Strength
15/100
overall scale · 30d index
Run
—
last seen 2d ago
Markets
1
countries seen
Landing page
forbes.com
final host
Screenshot
—
not captured yet
Operator
—
unidentified
Network
Outbrain
traffic source
Forbes Reveals Best GLP-1 Weight Loss Medications of 2026
Forbes | Sponsored@forbes
Beyond Ozempic: compare 2026’s leading GLP-1 treatments for appetite control, results, and long-term success.
Days alive is a profitability proxy — advertisers don’t pay to run losers.
Seen in
Geo reach
Single-geo testa single marketPredominantly Tier 1, concentrated in North America — United States.
What the data shows
Forbes | Sponsored's Outbrain creative has been running for 0 days across 1 country and first seen on June 14, 2026. It has been observed in United States. The ad lands on forbes.com. On our 30-day observation series the creative has run in intermittent bursts over the last 30 days. Forbes | Sponsored is running 8 other creatives we have indexed, linked below for side-by-side comparison.
Creative headline: Forbes Reveals Best GLP-1 Weight Loss Medications of 2026. Indexed on Outbrain by mediabuyer.
Landing-page intelligence
Landing page intelligence
Where this ad lands
The lander is the product — screenshot, redirect chain, offer, tech stack, and on-page text in one place.
Landing page not captured yet
Our crawler renders each advertiser’s funnel on a rolling schedule. Recently observed ads are queued first — check back to see the full-page screenshot.
Host
forbes.com
Path
/health/l/best-glp-1-medications-noom-v2/
Full URL
Redirect chain
Chain not captured yet.
Final host: forbes.com. Hop-by-hop capture runs as a separate pipeline; ads observed in recent ingests get crawled first.
Tracking parameters
- check
- b
- utm_campaign
- 004fa62c11fdc3ca6fd88487d1a82f17a8
- accountid
- 003cd3fca64f3e35c2760c979244e1e556
- utm_content
- [publisher_id]
- utm_term
- [publisher_name]
- network
- outbrain
- placement
- [publisher_id]
- creative
- 009bf4bac338ba0f4d92e3f9d3d0e18e0a
- utm_source
- outbrain
- utm_medium
- paid_native
- obclid
- [ob_click_id]
- ecom_creative
- 004fa62c11fdc3ca6fd88487d1a82f17a8
- obOrigUrl
- true
+ 1 known tracker hidden (cloaker IDs scrubbed at ingest).
Tracking setup · Outbrain
Outbrain emits ob_click_id (your unique click), ob_source (publisher), ob_section (placement), and ob_position. Forward ob_click_id to your tracker as the postback key. ob_source and ob_section are the two highest-signal sub-IDs for blacklisting.
?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}Default Outbrain setup template: ?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}
Tech stack
No third-party monetization stack detected — this appears to be a direct landing page.
Landing page hubs
Landing page text
On-page text not extracted yet.
Observed daily (last 30 days)
May 18 → Jun 15·peaks Jun 14
30-day run pattern
PulsedIntermittent runs with quiet stretches — likely paused for budget cycles or rotation against fresher creatives.
- Coverage
- 3% of 30d
- Peak surge
- 1× vs median
- Last 7d
- 1
- WoW
- new
Peak day:
Window: May 18 → Jun 15
Sibling creatives from this campaign
Other creatives in Content Arb on Outbrain
The rest of the set they’re running — see what else this angle is paired with.
Skip Ozempic! These Are The Best GLP-1 Medications of 2026
Skip Ozempic! Forbes Reveals Affordable GLP-1 Medications of 2026
These Miracle GLP-1 Treatments Are #1 For Weight Loss - Only $3/day
Forbes Reveals These GLP-1 Treatments Are #1 For Weight Loss - Only $3/day
Forbes Reveals Best GLP-1 Weight Loss Medications of 2026
Lock in Lowest Tirzepatide Price Ever - Only $79/month
Tested headline variants8
Tested headline variants
Forbes | Sponsored's own A/B test — which headline they kept
The advertiser’s own A/B result, handed over: ranked by days running, the survivor on top. Variants they stopped running are struck through — they tested and killed those angles.
- #1Skip Ozempic! These Are The Best GLP-1 Medications of 2026Winning angle40d6 content tokens
- #2Skip Ozempic! Forbes Reveals Affordable GLP-1 Medications of 20260d8 content tokens
- #3These Miracle GLP-1 Treatments Are #1 For Weight Loss - Only $3/day0d8 content tokens
- #4Forbes Reveals These GLP-1 Treatments Are #1 For Weight Loss - Only $3/day0d9 content tokens
Winning angle: the headline they kept alive longest — it beat the other variants they tested. Model this one; treat the rest as discarded experiments.
Persistent across variants: glp
More from Forbes | Sponsored8
More from Forbes | Sponsored
Most spy tools stop at the creative. This page connects it to the campaign behind it — the funnel, the longevity, the GEOs. Free.